Long-term survival in a cat with pancreatic adenocarcinoma treated with surgical resection and toceranib phosphate
Case summary Primary pancreatic adenocarcinoma is an uncommon neoplasm seen in cats and often has a poor prognosis. We report a case of an 8-year-old male neutered domestic shorthair cat weighing 5.8 kg diagnosed with pancreatic adenocarcinoma treated with surgical resection and toceranib phosphate,...
Main Authors: | Johanna E Todd, Sandra M Nguyen |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-06-01
|
Series: | Journal of Feline Medicine and Surgery Open Reports |
Online Access: | https://doi.org/10.1177/2055116920924911 |
Similar Items
-
Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma
by: Margaret L. Musser, et al.
Published: (2021-08-01) -
Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs
by: Hiroki Yamazaki, et al.
Published: (2020-05-01) -
Evaluation of toceranib for treatment of apocrine gland anal sac adenocarcinoma in dogs
by: Caitlin M. Heaton, et al.
Published: (2020-03-01) -
Toceranib phosphate-associated nephrotic syndrome in a dog: a case report
by: Shannon M. Remerowski, et al.
Published: (2021-04-01) -
Long-term survival after resections for pancreatic ductal adenocarcinoma. Single centre study
by: Martin Lovecek, et al.
Published: (2016-06-01)